1. Ewing WH. Edwards and Ewing's Identification of Enterobacteriaceae. 4th ed. New York: Elsevier Science Publishing; 1986. p.181-318.
2. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.
Proc Natl Acad Sci U S A. 1995;92(5):1664-1668.DOI:
10.1073/pnas.92.5.1664. PMID:
7878036. PMCID:
PMC42580.
4. Gyles CL.
Escherichia coli cytotoxins and enterotoxins.
Can J Microbiol. 1992;38(7):734-746.DOI:
10.1139/m92-120. PMID:
1393838.
5. Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM. Patterns of adherence of diarrheagenic
Escherichia coli to HEp-2 cells.
Pediatr Infect Dis J. 1987;6(9):829-831.DOI:
10.1097/00006454-198709000-00008. PMID:
3313248.
6. Finlay BB, Rosenshine I, Donnenberg MS, Kaper JB. Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic
Escherichia coli adherence to HeLa cells.
Infect Immun. 1992;60(6):2541-2543.DOI:
10.1128/iai.60.6.2541-2543.1992. PMID:
1587620. PMCID:
PMC257194.
7. Kaper JB. Defining EPEC. Rev Microbiol. 1996;27:130-133.
8. Park S, Kim SH, Kee HY, Seo JJ, Ha DR, Cho SH, et al. Enterotoxigenic Escherichia coli outbreak in a high school. Infect Chemother. 2006;38:30-38.
9. Jin YH, Seung HJ, Oh YH, Jung JH, Jeon SJ, Lee JK, et al. Epidemiological relationship of enterotoxigenic
Escherichia coli and enteroaggregative
E. coli isolated from patients with diarrhea in Seoul.
J Bacteriol Virol. 2013;43(1):37-44.DOI:
10.4167/jbv.2013.43.1.37.
10. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic
Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.
Clin Microbiol Rev. 2005;18(3):465-483.DOI:
10.1128/CMR.18.3.465-483.2005. PMID:
16020685. PMCID:
PMC1195967.
11. Vial PA, Robins-Browne R, Lior H, Prado V, Kaper JB, Nataro JP,
et al. Characterization of enteroadherent-aggregative
Escherichia coli, a putative agent of diarrheal disease.
J Infect Dis. 1988;158(1):70-79.DOI:
10.1093/infdis/158.1.70. PMID:
2899125.
12. Savarino SJ, Fox P, Deng Y, Nataro JP. Identification and characterization of a gene cluster mediating enteroaggregative
Escherichia coli aggregative adherence fimbria I biogenesis.
J Bacteriol. 1994;176(16):4949-4957.DOI:
10.1128/jb.176.16.4949-4957.1994. PMID:
7914189. PMCID:
PMC196332.
13. Brenner DJ, Fanning GR, Miklos GV, Steigerwalt AG. Polynucleotide sequence relatedness among
Shigella species.
Int J Syst Bacteriol. 1973;23(1):1-7.DOI:
10.1099/00207713-23-1-1.
14. Ménard R, Dehio C, Sansonetti PJ. Bacterial entry into epithelial cells: the paradigm of
Shigella.
Trends Microbiol. 1996;4(6):220-226.DOI:
10.1016/0966-842X(96)10039-1. PMID:
8795157.
15. Pupo GM, Lan R, Reeves PR. Multiple independent origins of
Shigella clones of
Escherichia coli and convergent evolution of many of their characteristics.
Proc Natl Acad Sci U S A. 2000;97(19):10567-10572.DOI:
10.1073/pnas.180094797. PMID:
10954745. PMCID:
PMC27065.
17. Dixon B. Antibiotics as growth promoters: risks and alternatives. ASM news. 2000;66(5):264-265.
18. Heinemann JA, Ankenbauer RG, Amábile-Cuevas CF. Do antibiotics maintain antibiotic resistance?
Drug Discov Today. 2000;5(5):195-204.DOI:
10.1016/S1359-6446(00)01483-5. PMID:
10790263.
19. Ahmed AM, Motoi Y, Sato M, Maruyama A, Watanabe H, Fukumoto Y, et al. Zoo animals as reservoirs of gram-negative bacteria harboring integrons and antimicrobial resistance genes.
Appl Environ Microbiol. 2007;73(20):6686-6690.DOI:
10.1128/AEM.01054-07. PMID:
17720829. PMCID:
PMC2075039.
20. Lanz R, Kuhnert P, Boerlin P. Antimicrobial resistance and resistance gene determinants in clinical
Escherichia coli from different animal species in Switzerland.
Vet Microbiol. 2003;91(1):73-84.DOI:
10.1016/S0378-1135(02)00263-8. PMID:
12441233.
21. Kim JG. Influence of climate factors on the occurrence of pathogenic Escherichia coli food poisoning in Korea. J Environ Health Sci. 2020;46(3):353-358.
22. WHO. Shiga Toxin-producing Escherichia coli (STEC) and Food: Attribution, Characterization and Monitoring: Report. World Health Organization, 2018.
23. Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic
Escherichia coli.
Emerg Infect Dis. 2002;8(5):508-513.DOI:
10.3201/eid0805.010385. PMID:
11996687. PMCID:
PMC2732489.
24. Yun YS, Kim NO, Hong SH, Chun JH, Hwang KJ. The prevalence of pathogenic Escherichia coli isolated by the enteric pathogens active surveillance network (Enter-Net), 2010-2019. Pub Health Wkly Rep. 2020;13:2860-2870.
26. Price J, Ekleberry A, Grover A, Melendy S, Baddam K, McMahon J, et al. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit.
Crit Care Med. 1999;27(10):2118-2124.DOI:
10.1097/00003246-199910000-00007. PMID:
10548192.
27. Kim KA, Yong KC, Jeong JA, Huh JW, Hur ES, Park SH, et al. Analysis of Epidemiological Characteristics, PFGE Typing and Antibiotic Resistance of Pathogenic
Escherichia coli Strains Isolated from Gyeonggi-do.
Kor J Microbiol. 2014;50(4):285-295.DOI:
10.7845/kjm.2014.4057.
28. Kim JY, Jeon SM, Kim H, Lim N, Park MS, Kim SH. Resistance to Fluoroquinolone by a Combination of Efflux and Target Site Mutations in Enteroaggregative
Escherichia coli Isolated in Korea.
Osong Public Health Res Perspect. 2012;3(4):239-244.DOI:
10.1016/j.phrp.2012.11.002. PMID:
24159520. PMCID:
PMC3747663.
29. Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative
Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern.
Int J Infect Dis. 2011;15(2):e136-139.DOI:
10.1016/j.ijid.2010.10.002. PMID:
21130676.
30. Kennedy CA, Walsh C, Karczmarczyk M, O'Brien S, Akasheh N, Quirke M,
et al. Multi-drug resistant
Escherichia coli in diarrhoeagenic foals: Pulsotyping, phylotyping, serotyping, antibiotic resistance and virulence profiling.
Vet Microbiol. 2018;223:144-152.DOI:
10.1016/j.vetmic.2018.08.009. PMID:
30173740.
31. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
Clin Microbiol Rev. 2001;14(4):933-951.DOI:
10.1128/CMR.14.4.933-951.2001. PMID:
11585791. PMCID:
PMC89009.
33. Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.
J Antimicrob Chemother. 2017;72(8):2145-2155.DOI:
10.1093/jac/dkx146. PMID:
28541467.
34. Kim YA, Kim H, Seo YH, Park GE, Lee H, Lee K. Prevalence and Molecular Epidemiology of Extended-Spectrum-β-Lactamase (ESBL)-Producing
Escherichia coli From Multiple Sectors of the Swine Industry in Korea: A Korean Nationwide Monitoring Program for a One Health Approach to Combat Antimicrobial Resistance.
Ann Lab Med. 2021;41(3):285-292.DOI:
10.3343/alm.2021.41.3.285. PMID:
33303713. PMCID:
PMC7748096.
35. Kim MS, Kwon HM, Sung HW. Antibiotic resistance pattern of avian pathogenic Escherichia coli isolated from chickens. Korean J Vet Res. 2009;49(3):195-200.